ArticleFrontiers in endocrinology2026

Ipilimumab and nivolumab for cancer treatment: a pharmacovigilance study based on the FDA adverse event reporting system database.

Ruming Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.